In a continuing collaboration in a search for new antiproliferative compounds in Madagascar as part of an International Cooperative Biodiversity Group (ICBG), an ethanol extract of Molinaea retusa Radlk. (Sapindaceae) was investigated on the basis of its moderate antiproliferative activity against the A2780 human ovarian cancer cell line (IC 50 16 µg/mL). One new compound, 2'',3'',4'',6'-de-O-acetylcupacinoside (1, IC 50 15.4 μM) and two known compounds, cupacinoside (2, IC 50 9.5 μM) and 6-de-O-acetylcupacinoside (3, IC 50 10.9 μM), were isolated by bioassay-directed fractionation using liquid-liquid partitioning, column chromatography, and HPLC. Compounds 2 and 3 also had moderate antiplasmodial activities, with IC 50 values of 4.0 and 6.4 μM, respectively, against Plasmodium falciparum, Dd2 strain. The structures were determined using spectroscopic methods.
As a part of the Madagascar International Cooperative Biodiversity Group (ICBG) program [1] an ethanol extract of Molinaea retusa Radlk. was found to have moderate antiproliferative activity (IC 50 16 µg/mL) against the A2780 cell line, and the extract was selected for evaluation. Molinaea retusa is a member of the Sapindaceae family which contains approximately 135 genera and 1,600 species [2] . While plants of the Sapindaceae family have been the subject of multiple phytochemical studies, the genus Molinaea has not previously been investigated.
Plants of the Sapindaceae family are known to contain terpenoids, flavonoids, and ceramides, with varying types of activity, including antiproliferative and antiplasmodial activities [3] . Molinaea retusa is one of ten members of the Molinaea genus, all of which are endemic to Madagascar [2] . During this study, one unreported compound, 2'',3'',4'',6'-de-O-acetylcupacinoside (1, IC 50 15.4 μM) ( Figure 1 ) and two known compounds, cupacinoside (2, IC 50 9.5 μM, 4.0 μM) and 6'-de-O-acetylcupacinoside (3, IC 50 10.9 μM, 6.4 μM) ( Figure 1 ) were isolated (IC 50 values against the A2780 ovarian cancer cell line and Plasmodium falciparum strain Dd2, respectively) [3a] . Compounds 2 and 3 were previously isolated from Cupania cinerea (Sapindaceae) with activities of 1.3 μM (2) and 2.1 μM (3) against P. falciparum (K1 strain) and activities of 11.6 μM (2) and 8.7 μM (3) against rat skeletal myoblast cells (L-6 cell line) [3a] .
Liquid/liquid partitioning of an EtOH extract of M. retusa (IC 50 16 µg/mL) yielded an active EtOAc fraction (IC 50 10 µg/mL). Further bioassay-guided isolation, including the use of C 18 reverse phase chromatography and amino normal phase chromatography, yielded three bioactive compounds with moderate antiproliferative activity exhibited against the A2780 ovarian cancer cell line. Two of the compounds, cupacinoside (2) and 6'-de-O-acetylcupacinoside (3) have previously been reported and were identified through comparison of 1 H NMR, 13 C NMR, and HRESIMS spectroscopic data with previously published data [3a] .
The previously unreported compound 1 (IC 50 15.4 μM) was also isolated. The structure of compound 1 was found to be very similar to 2 and 3 based on comparison of their 1 H NMR and 13 C NMR spectroscopic data. The 1 H NMR and 13 C NMR showed that five methyl groups ( 1.60, 6H, s; 1.60, 3H, s; 1.61, 3H, s; 1.67, 3H, s; and 1.70, 3H, s) together with a broad triplet at 5.39 were present, consistent with the presence of a geranylgeraniol group as found in 2 and 3 [3a] . The 1 H and 13 C NMR spectra exhibited two anomeric protons, suggesting the presence of two sugar units. The signal in the 1 H NMR spectrum at 4.35 (d, J = 7.7 Hz) is indicative of the anomeric proton on a β-glucopyranosyl unit. The remaining carbon and proton signals for the glucopyranosyl moiety were assigned through HSQC and HMBC correlations and have shifts corresponding to glucopyranosyl based on comparison with published literature data [3a] . The doublet (J = 6.2 Hz) signal at rhamnopyranosyl unit. The anomeric proton signal was assigned as 5.12 through use of HMBC and HMQC correlations. The coupling constant could not be directly obtained, due to overlap of signals in the 1 H NMR spectrum, but could be inferred through the coupling constant present for the H-2'' signal (dd, J = 3.4, 1.7 Hz). Since 3.4 Hz represents the coupling of H-2'' to H-3'', the coupling of 1.7 Hz represents of coupling of H-1'' to H-2''. Furthermore, the chemical shift of C-5'' ( 69.8) is consistent with an α-rhamnopyranosyl group [4] .
Assignments of protons and carbons for the α-rhamnopyranosyl unit were made based on HMBC and HSQC correlations and coupling constants present in the 1 H NMR spectrum. A correlation in the HMBC from H-1 to C-1' indicated that β-glucopyranosyl was attached to the aglycone, and a correlation from H-1'' to C-2' indicated the α-rhamnopyranosyl is connected to the β-glucopyranosyl unit at the 2' position ( Figure 2 ). The aglycone connectivity and sugar linkage were thus confirmed to be the same in 1 as in 2 and 3, as expected due to the similarity of their spectroscopic data.
In comparison to 2 and 3, H-2'', H-3'', and H-4'' of 1 were shifted upfield (ca. ppm); conversely, C-2'', C-3'', and C-4'' were shifted downfield (ca. +ppmwhich is in agreement with the lack of acetylation. The 13 C NMR spectrum further indicated a lack of acetylation due to the absence of peaks downfield of 160. The molecular formula (C 32 H 54 O 10 ) was established using HRESIMS which yielded an ion at m/z 643.3727 corresponding to [M+HCOO]  (calcd. 643.3694 for C 33 H 55 O 12 ). Compound 1 was thus determined to be 2'',3'',4'',6'-de-O-acetylcupacinoside Antiproliferative activities of compounds 1 -3 against a human ovarian cancer cell line (A2780) were comparable to published activities against a rat skeletal myoblast cell line (L-6). Likewise antimalarial activities against P. falciparum (Dd2 strain) were comparable to previously reported activities against P. falciparum (K1 strain) [3a] . using a flash chromatography fraction collector, and yielded one active sub-fraction (140 mg, IC 50 9 g/mL). The sub-fraction was fractionated further on a flash chromatography fraction collector utilizing a silica gel column with a hexanes/EtOAc gradient yielding compound 3 (25 mg, IC 50 10.9 M) and one other active fraction (55 mg, IC 50 9 g/mL). The active fraction was fractionated further through the use of an open silica gel column (EtOAc mobile phase) yielding compound 2 (7 mg, IC 50 9.5 M). A second fractionation was carried out to isolate a minor active compound detected during
